BBV152/BBV154
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BBV152/BBV154, covering 2022-12-07 to 2022-12-07. Get the full timeline:
Most recent: Clinical Trial Update: BBV152/BBV154 Heterologus Prime-Boost Study [Phase 2]